rs4379175

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000641150.1(IL12B-AS1):​n.532+23799G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.357 in 151,948 control chromosomes in the GnomAD database, including 9,848 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 9848 hom., cov: 32)

Consequence

IL12B-AS1
ENST00000641150.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.146

Publications

18 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000641150.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.422 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000641150.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12B-AS1
ENST00000635333.1
TSL:5
n.283-14613G>T
intron
N/A
IL12B-AS1
ENST00000641150.1
n.532+23799G>T
intron
N/A
IL12B-AS1
ENST00000648969.1
n.53+23799G>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.357
AC:
54173
AN:
151830
Hom.:
9836
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.408
Gnomad AMI
AF:
0.303
Gnomad AMR
AF:
0.357
Gnomad ASJ
AF:
0.287
Gnomad EAS
AF:
0.437
Gnomad SAS
AF:
0.369
Gnomad FIN
AF:
0.307
Gnomad MID
AF:
0.370
Gnomad NFE
AF:
0.330
Gnomad OTH
AF:
0.369
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.357
AC:
54215
AN:
151948
Hom.:
9848
Cov.:
32
AF XY:
0.356
AC XY:
26449
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.408
AC:
16908
AN:
41440
American (AMR)
AF:
0.357
AC:
5452
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.287
AC:
994
AN:
3468
East Asian (EAS)
AF:
0.437
AC:
2258
AN:
5162
South Asian (SAS)
AF:
0.369
AC:
1776
AN:
4818
European-Finnish (FIN)
AF:
0.307
AC:
3227
AN:
10528
Middle Eastern (MID)
AF:
0.364
AC:
107
AN:
294
European-Non Finnish (NFE)
AF:
0.330
AC:
22438
AN:
67952
Other (OTH)
AF:
0.370
AC:
780
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1767
3535
5302
7070
8837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
528
1056
1584
2112
2640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.345
Hom.:
5556
Bravo
AF:
0.362
Asia WGS
AF:
0.448
AC:
1558
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
8.0
DANN
Benign
0.43
PhyloP100
0.15

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4379175;
hg19: chr5-158804928;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.